{"name":"Juventas Therapeutics, Inc.","slug":"juventas-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ACRX-100","genericName":"ACRX-100","slug":"acrx-100","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ACRX-100","genericName":"ACRX-100","slug":"acrx-100","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPRGdOSUR3S1F3TjNiLWtyb09MbmpmMmhmMFpYcmZqempEWWtIVVBVWkNZSUlva1c5bE15QnFBbmhZZ3o3dktuZHhkUFRUdlZFdDlfd3JCeVcyaEtIVzV4aDlIcVFwX19rdnJkSkVwOExHVzhTdlJyTEtTYTZrQlVRdHF3RG9xYWhUTmxMektrUWVoSjU1RUVKQXEzWjg0N25QcFQ1cl9qMDVKS1FneDJhWmQ4cE5pVDMwT1lEeWhMeVB0UQ?oc=5","date":"2025-12-01","type":"regulatory","source":"BioPharma APAC","summary":"Juventas’ CAR-T Therapy Ina-cel Receives NMPA Approval for Large B-Cell Lymphoma - BioPharma APAC","headline":"Juventas’ CAR-T Therapy Ina-cel Receives NMPA Approval for Large B-Cell Lymphoma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQbGlsSU8zMjNtYmNtUnlnMHI4Y3hsV011XzRLcVJ5dnVoZTE0QTJQYy11Q3RFbHFQS0RFTkNTcnRmYWc1aVMtNFY0bnZKTmRlTDVNRHRJcllPaU1La1N1MVdRb3VHdjFiX3E3ekFFWlpaVTFxNHlDMEx1dVZSRjJPSWZHWGZlNjNoQ2RSTWZTWXJjVDQ4a2NWS0JpQTBLUGhnTjVZZVdoM2xvWDQyY3NNQWQzNTBFdHRBLVBaMFkzNmM5Wkt0ZjJQc3hlZ25uN0Rp?oc=5","date":"2024-07-19","type":"pipeline","source":"PR Newswire","summary":"CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS - PR Newswire","headline":"CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQbUNZYXNKSVY0T0l2ZXdmdW92bmVHcWVzUmFzM3FSbG5IeVBuZG1OazJFaERNMmMzNG4tT1JHS3ZrWVk1b1c0aTlINHdSQkRqa1JVdzZ6d2xIT2UxejNKeVAzTUx6Z0Y2NzdZc015dzRINGp6UUprYTR0NXZzMUpkeVZWa2t3Sm9pVjNOQ2h3S0F0cDJYS0JEeG5iQ0U?oc=5","date":"2024-04-24","type":"pipeline","source":"BioWorld News","summary":"China grapples with providing access to CAR T therapies - BioWorld News","headline":"China grapples with providing access to CAR T therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOYmNHY1BHeW9pVVpSaXZqT2ZtNHpZY01jdEZqdl9KZE5mUVNnR21icHBnN2UyYXNzMkZLU3RVdG5LZl9fQ01hWW01TGpJQVpwQk4wc25PZXF3R2JuSU91dVpMcUh4ek1seHVja3kzV043WERYbHpMZG5fX05yYzkxWmkxSXREV3FIZkt1VDd3bkhXTkpwbjdNZjd2cGF2bG9Ea3B1cVFoQlEtUzdC?oc=5","date":"2024-04-22","type":"trial","source":"BioWorld News","summary":"China’s investigator trials accelerate competitive CAR T development - BioWorld News","headline":"China’s investigator trials accelerate competitive CAR T development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOZTJxY3IxVWdDRWY1c3lVYlRaejFsYTBVc3JsOE9Zbk1Oc0lYb2hUNkItLWp5QXBLcDNQSlk4RHJMdzdMNGNfSmJLRUxVNHJiQmtrcVMxalJQc0JHamJpYUZGVkpGZkpWWWpjRzJpUkhQVEprUWlNQXUtWk0taTVQS09fN1hRd285bk90TEh0SXVvUWxlNnZCQkxuSQ?oc=5","date":"2023-11-08","type":"regulatory","source":"BioSpace","summary":"CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA - BioSpace","headline":"CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOMnd6RFc0dzlPMjUzN0FZdmhtU3YtelNqd1FmaEp0YS1Ia3NWZndwYVJxX0huZmRFTnBIUU0wZHFFVUZkQUxNNXprQWxyQXZSOEp1WkxsTmRiYm5iREFnSTFxT2Q1LXJLQkZnV2FRbGk0RE4yZjVDdU1DVmtKOEsteXNEZHJjZE8wclRFZmw3Q0tnVV8wRy1qalU4enBNbUNSVUhVTEhhMUdGRzlfaG9B?oc=5","date":"2023-10-30","type":"pipeline","source":"Business Wire","summary":"Rapport Therapeutics Appoints Chief Financial Officer - Business Wire","headline":"Rapport Therapeutics Appoints Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNUHBUeGcycUNNQTJ5dkFFeVd0WDVBTk16aUhiNHo3c0FCYVk0OHpSRXI3dXd3aWRvZUNYVUxHTEIxclowUWNDS1ZIamY2U0hESk9SZ1ZPUU9XMkxFVmMybnVON3QtNGxiajlJcVdKb0s5VGRZMGJ4OEcxNEFjUUpaMU5PYw?oc=5","date":"2022-12-16","type":"pipeline","source":"Pharmaceutical Technology","summary":"China NMPA accepts Juventas’ NDA for leukaemia treatment - Pharmaceutical Technology","headline":"China NMPA accepts Juventas’ NDA for leukaemia treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQSXhZWW85VGZ5SVB0VkRnRjRJdkJNby03ODgtZE1heWRkTkNPUzBoNC1VMHFuMjVWNzQ0X29JRlFhZ0Y4TXJKZ0xna3lWNG1WWUlETkF0b3VxMWdmSkZ4eWZpYVdwZTVKc3RDLWs5dzNDb2tKZUlVRWdEcEg5YVpOZ1VrWTd1ajhLZDZIQTlaNlFTejJmcnEyOUdHMWRiVzZ6TVZxSmptNTZIRHo4RXNDdVF4ek1Lb2drRUJ5WWRscHhkcHdfZVdid2FJQUYxUjdEQlM2emVTTVE0N0MwV19RVGJlbFk2VUc3NUhna012TDNlRHlacXdRSlZnZ0Nkajg1dl8tT3llcjFvdEk0TTZibTZia1JfRFNFcDFrTTIyYw?oc=5","date":"2022-12-15","type":"deal","source":"PR Newswire","summary":"CASI PHARMACEUTICALS' PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION - PR Newswire","headline":"CASI PHARMACEUTICALS' PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PROD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQUWZuZFlyV3l6Y255ZE12ZlhjUXhnVko4WUR2Rk1abnk0bDVtbnlYckJNZ3NIMWdWWXJTZEtDcFRwU00tVlh6RVg3R1M1ZzhFdVlZUzhpbGlUdGFraGIzVTJKSDNUY1U3QjNkQzgwX1NycGZDMGs4cmxHcUhnQlFZUXl0TW1mVjZ0d1JpTHJMejg2WVp5YlljV2hfSno5YzVSR0ZGYUZkQl94OUxvamFXSE9vdEEydlpGejNkbXBzbFFKTDg0VFliNnA4U0NmZDNRNTBfa3RaQ19wdw?oc=5","date":"2022-09-23","type":"pipeline","source":"PR Newswire","summary":"CASI PHARMACEUTICALS ANNOUNCES EXIT OF JUVENTAS INVESTMENT TO STRENGTHEN BALANCE SHEET - PR Newswire","headline":"CASI PHARMACEUTICALS ANNOUNCES EXIT OF JUVENTAS INVESTMENT TO STRENGTHEN BALANCE SHEET","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxPb05BRGhlWGtVSzNvZFZicnRDeDZ2Q3ZVSlktelNma3ZDbEJlVnNVUHY5ckh4Y3ZETE1zRmw2bnZzdnFLdUI2elJvMmhJVU0xeWhYRXhqcU81NEVMejM2NjhXQlBKd2tsc3VYWkc3cldZbTZ6RVp6aGNKVHVPUTZOWDh1VXVUdV90WFVUd21aNFlHTFVSdjRiZnVxYWlsb09Tdi1hQ3VtNTRTN19FZ3ZjUWZwTjhRaGdsQ2dTUTRWUktwMFBkb2hQcWdBWGJFcHk4UEE2WEEyclE1eU9FbGNCNENGX1gzTTE4cFhVUWtmeXd3WjVaNVV6VDl4c3daMmlNakNTWXlteUdTVWlPVmx0SzRTQkFXMWpPbC1WcVNtZDVFZWRLUXV5Z3hfTUZQa0pDcHU0YlotUG5KRlFLMnpnOEdrY3J3ZU1CS0NqcHhB?oc=5","date":"2021-10-25","type":"trial","source":"PR Newswire","summary":"CASI Pharmaceuti­­­cals Announces Partner Juventas Completion Of Series C Financing Of $63 Million (RMB410 Million) For Acceleration Of CNCT19 Pivotal Trials And Commercialization - PR Newswire","headline":"CASI Pharmaceuti­­­cals Announces Partner Juventas Completion Of Series C Financing Of $63 Million (RMB410 Million) For ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNSld5bjBkN1hwaEFYaVB0THdScWw2SnVzSm16V3hsT2JJNnJRbVplRUdpZE5LdXZjczVJUF9wT1VnRHUwejJHRUxYeV9qYllWVXAteVpzRUg0di1WTW4tVTIwTE9DaXdhNGg3aHdRRkZHcnVlMEI5UDRrTDRSeU85cURFbVFLUFF4MkNXb1gzeWRpM2Q0NmNVUVZKLWk2NUM5VTBJZmFQc0dSV0FkOE5JZ1pJbGZYZw?oc=5","date":"2020-09-29","type":"deal","source":"BioSpace","summary":"CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy Ltd - BioSpace","headline":"CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell Therapy Ltd","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}